Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
British Journal of Cancer|June 8, 2019
Cancer screening and prevention in BRCA mutation carriers: a missed opportunity?Nathalie LeVasseur, Stephen Chia
Current Oncology (Toronto, Ont.)|July 25, 2022
Current and New Novel Combination Treatments for Metastatic Triple-Negative Breast CancerMehrnoosh Pauls, Stephen Chia, Nathalie LeVasseur
Current Oncology (Toronto, Ont.)|August 28, 2024
An Overview of Long-Acting GnRH Agonists in Premenopausal Breast Cancer Patients: Survivorship Challenges and ManagementNathalie LeVasseur, Mita Manna, Katarzyna J Jerzak
Cancer Treatment Reviews|October 8, 2016
Bone-targeted therapy use in patients with bone metastases from lung cancer: A systematic review of randomized controlled trialsNathalie LeVasseur, Mark Clemons, Brian Hutton, et al.
Cancers|April 14, 2026
The Evolution of Targeted Therapies in Early Hormone Receptor-Positive, HER2-Negative Breast CancerHyejee Ohm, Caroline Lohrisch, Nathalie LeVasseur, et al.
Journal of Cancer Research and Clinical Oncology|November 20, 2019
Impact of pathologic complete response on survival after neoadjuvant chemotherapy in early-stage breast cancer: a population-based analysisNathalie LeVasseur, J Sun, L Gondara, et al.
Clinical Breast Cancer|August 1, 2022
Locoregional Recurrence and Survival Outcomes in Breast Cancer Treated With Modern Neoadjuvant Chemotherapy: A Contemporary Population-based AnalysisSonja Murchison, Alan Nichol, Caroline Speers, et al.
Journal of Neuro-Oncology|November 18, 2020
Type and timing of systemic therapy use predict overall survival for patients with brain metastases treated with radiation therapyKevin Yijun Fan, Nafisha Lalani, Nathalie LeVasseur, et al.
International Journal of Radiation Oncology, Biology, Physics|August 28, 2020
Breast Cancer Molecular Subtype as a Predictor of Radiation Therapy Fractionation SensitivityNafisha Lalani, K David Voduc, Rachel B Jimenez, et al.
Clinical Breast Cancer|July 8, 2019
Efficacy of Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in ER-positive Breast Cancer: Results From a Prospective Institutional DatabaseNathalie LeVasseur, Kaylie-Anne Willemsma, Huaqi Li, et al.
Pageof 3